Financial Statements

Ironwood Pharmaceuticals, Inc. (IRWD)


-0.04 (-0.39%)
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers are in thousands

Retained Earning Schedule

Year 2021 2020 2019 2018 2017
Retained Earnings (Previous Year) -1,466-1,572-1,591-1,309-
Net Income 52810622-282-117
Stock Dividends ---3--1,192
Dividend Paid -----
Retained Earnings -938-1,466-1,572-1,591-1,309

PPE Schedule

Year 2021 2020 2019 2018 2017
Gross PPE 26301717-
Annual Depreciation -2-320921
Capital Expenditure -0-2-7-9-4
Net PPE 2326301717

Intangible and Goodwill Schedule

Year 2021 2020 2019 2018 2017
Intangible and Goodwill (Previous Year) -1111
New Purchases -191-3---
Intangible and Goodwill 1111-

Ironwood Pharmaceuticals, Inc. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes Ironwood Pharmaceuticals, Inc. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.